Puma Biotechnology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PBYI and other ETFs, options, and stocks.About PBYI
Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer.
CEOAlan H. Auerbach
CEOAlan H. Auerbach
Employees172
Employees172
HeadquartersLos Angeles, California
HeadquartersLos Angeles, California
Founded2010
Founded2010
Employees172
Employees172
PBYI Key Statistics
Market cap246.41M
Market cap246.41M
Price-Earnings ratio6.60
Price-Earnings ratio6.60
Dividend yield—
Dividend yield—
Average volume701.75K
Average volume701.75K
High today$5.03
High today$5.03
Low today$4.85
Low today$4.85
Open price$4.91
Open price$4.91
Volume418.34K
Volume418.34K
52 Week high$6.12
52 Week high$6.12
52 Week low$2.58
52 Week low$2.58
Stock Snapshot
Puma Biotechnology(PBYI) stock is priced at $4.89, giving the company a market capitalization of 246.41M. It carries a P/E multiple of 6.60.
On 2025-11-22, Puma Biotechnology(PBYI) stock moved within a range of $4.85 to $5.03. With shares now at $4.89, the stock is trading +0.8% above its intraday low and -2.8% below the session's peak.
Trading activity shows a volume of 418.34K, compared to an average daily volume of 701.75K.
The stock's 52-week range extends from a low of $2.58 to a high of $6.12.
The stock's 52-week range extends from a low of $2.58 to a high of $6.12.
People also own
Based on the portfolios of people who own PBYI. This list is generated using Robinhood data, and it’s not a recommendation.